Spyre Therapeutics Inc (SYRE)
43.88
+0.99%
Spyre Therapeutics Inc (SYRE) is currently trading at $43.88. This represents a gain of 0.99% from the previous session. With a market capitalization of $3.45B, SYRE is a key component of the Health Care sector. Investors looking to trade SYRE should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade SYRE commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Spyre Therapeutics Inc (SYRE) shows a bullish trend. Analysts are watching the 44.88 level closely.
Fundamentals
Mkt Cap3.45B
P/E Ratio0.0000
Volume521,817
60-Day Technical Chart
Advanced Charting
Need more indicators for SYRE? Use the world's #1 platform.
Open SYRE on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $44
| Metric |
SYRE +0.99% |
INTC +1.65% |
PYPL +0.58% |
CSGP -8.89% |
|---|---|---|---|---|
| Price | $43.88 | $46.88 | $47.30 | $44.78 |
| Mkt Cap | $3.45B | $234.17B | $43.54B | $18.98B |
| - | View → | View → | View → |
Latest Headlines
Biotech Spyre lines up Boston and Miami investor talks in March
Stock Titan • Feb 24, 2026
$SYRE stock is up 13% today. Here's what we see in our data.
Quiver Quantitative • Feb 20, 2026
Spyre Therapeutics (SYRE) Buy Rating Reiterated by BTIG | SYRE S
GuruFocus • Feb 21, 2026
Wall Street Bullish on Spyre Therapeutics, Inc. (SYRE) with Strong Buy Rating
Yahoo Finance • Jan 15, 2026
Spyre Therapeutics (SYRE) Set POC Readout Priorities for 2026
Bitget • Feb 16, 2026
● Gemini Agentic AI Analyst Insight for SYRE
Market Education
- Long Short Strategy to Manage Risk May 31, 2024
- Want to be a Wall street billionaire, take their investing advice Jul 19, 2023
- Every trader should read this handy guide- Tools & Reference Jul 15, 2023
External Research